Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor

NCT04684368 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT04684368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04684368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Recruiting
Start date
July 13, 2021
Completion date
December 21, 2029
Enrollment
160 (estimated)
Sites
170

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system nongerminomatous germ cell tumor, choriocarcinoma, embryonal carcinoma, immature teratoma, malignant teratoma, mixed germ cell tumor, pineal region germ cell tumor, pineal region immature teratoma, pineal region yolk sac tumor, suprasellar germ cell tumor